drugset / Trial / NCT00554099
Asacol Acute Diverticulitis(DIVA)Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.
Timeline
- Start
- 2007-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bifidobacterium infantis 35624 | Other / unclassified | — | — |
| Comparator | Mesalamine | Small molecule | 400 mg | — |